Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2015-10-26

Clinical Trial Update: UARK 2009-32 Compassionate Use Study of Carfilzomib

View source ↗

Summary

Compassionate-use study of carfilzomib for multiple myeloma is no longer available (status NO_LONGER_AVAILABLE).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Carfilzomib (carfilzomib)

Snippet

Sponsor: University of Arkansas | Conditions: Multiple Myeloma | Status: NO_LONGER_AVAILABLE